BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen W, Liu P, Wang Y, Nie W, Li Z, Xu W, Li F, Zhou Z, Zhao M, Liu H. Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma. PLoS One 2013;8:e76965. [PMID: 24194851 DOI: 10.1371/journal.pone.0076965] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Yu X, Wei B, Su R, Yao J, Feng X, Jiang G, Xie H, Wu J, Xu X, Zhang M, Zheng S, Zhou L. A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276. Mol Genet Genomic Med 2019;7:e689. [PMID: 31044564 DOI: 10.1002/mgg3.689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Flem-Karlsen K, Fodstad Ø, Nunes-Xavier CE. B7-H3 Immune Checkpoint Protein in Human Cancer. Curr Med Chem 2020;27:4062-86. [PMID: 31099317 DOI: 10.2174/0929867326666190517115515] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
3 Zhong C, Tao B, Chen Y, Guo Z, Yang X, Peng L, Xia X, Chen L. B7-H3 Regulates Glioma Growth and Cell Invasion Through a JAK2/STAT3/Slug-Dependent Signaling Pathway. Onco Targets Ther 2020;13:2215-24. [PMID: 32210587 DOI: 10.2147/OTT.S237841] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Purvis IJ, Avilala J, Guda MR, Venkataraman S, Vibhakar R, Tsung AJ, Velpula KK, Asuthkar S. Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis. J Clin Med 2019;8:E1158. [PMID: 31382461 DOI: 10.3390/jcm8081158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
5 Ni L, Dong C. New checkpoints in cancer immunotherapy. Immunol Rev 2017;276:52-65. [DOI: 10.1111/imr.12524] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 14.2] [Reference Citation Analysis]
6 Wang B, Wang B, Liu P, Li T, Si W, Xiu J, Liu H. Package of NDV-pseudotyped HIV-Luc virus and its application in the neutralization assay for NDV infection. PLoS One 2014;9:e99905. [PMID: 24937158 DOI: 10.1371/journal.pone.0099905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
7 Li Y, Guo G, Song J, Cai Z, Yang J, Chen Z, Wang Y, Huang Y, Gao Q. B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway. J Cancer 2017;8:816-24. [PMID: 28382144 DOI: 10.7150/jca.17759] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
8 Yoon BR, Chung YH, Yoo SJ, Kawara K, Kim J, Yoo IS, Park CG, Kang SW, Lee WW. Preferential Induction of the T Cell Auxiliary Signaling Molecule B7-H3 on Synovial Monocytes in Rheumatoid Arthritis. J Biol Chem 2016;291:4048-57. [PMID: 26702052 DOI: 10.1074/jbc.M115.680298] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Picarda E, Ohaegbulam KC, Zang X. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy. Clin Cancer Res. 2016;22:3425-3431. [PMID: 27208063 DOI: 10.1158/1078-0432.ccr-15-2428] [Cited by in Crossref: 174] [Cited by in F6Publishing: 122] [Article Influence: 29.0] [Reference Citation Analysis]
10 Nakashima T, Liu T, Hu B, Wu Z, Ullenbruch M, Omori K, Ding L, Hattori N, Phan SH. Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow. Am J Respir Crit Care Med 2019;200:1032-44. [PMID: 31106564 DOI: 10.1164/rccm.201808-1560OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Li N, Spetz MR, Li D, Ho M. Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3. Pharmacol Ther 2021;223:107892. [PMID: 33992682 DOI: 10.1016/j.pharmthera.2021.107892] [Reference Citation Analysis]
12 Liu C, Zhang G, Xiang K, Kim Y, Lavoie RR, Lucien F, Wen T. Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy. Cancer Immunol Immunother 2021. [PMID: 34739560 DOI: 10.1007/s00262-021-03097-x] [Reference Citation Analysis]
13 Gu D, Ao X, Yang Y, Chen Z, Xu X. Soluble immune checkpoints in cancer: production, function and biological significance. J Immunother Cancer 2018;6:132. [PMID: 30482248 DOI: 10.1186/s40425-018-0449-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 14.8] [Reference Citation Analysis]
14 Sadreddini S, Baradaran B, Aghebati-Maleki A, Sadreddini S, Shanehbandi D, Fotouhi A, Aghebati-Maleki L. Immune checkpoint blockade opens a new way to cancer immunotherapy. J Cell Physiol 2019;234:8541-9. [PMID: 30511409 DOI: 10.1002/jcp.27816] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 9.3] [Reference Citation Analysis]
15 Son Y, Kwon SM, Cho JY. CD276 (B7-H3) Maintains Proliferation and Regulates Differentiation in Angiogenic Function in Late Endothelial Progenitor Cells. Stem Cells 2019;37:382-94. [PMID: 30379377 DOI: 10.1002/stem.2944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
16 Flem-Karlsen K, Tekle C, Andersson Y, Flatmark K, Fodstad Ø, Nunes-Xavier CE. Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells. Pigment Cell Melanoma Res 2017;30:467-76. [PMID: 28513992 DOI: 10.1111/pcmr.12599] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
17 Zhou WT, Jin WL. B7-H3/CD276: An Emerging Cancer Immunotherapy. Front Immunol 2021;12:701006. [PMID: 34349762 DOI: 10.3389/fimmu.2021.701006] [Reference Citation Analysis]
18 Lim S, Liu H, Madeira da Silva L, Arora R, Liu Z, Phillips JB, Schmitt DC, Vu T, McClellan S, Lin Y, Lin W, Piazza GA, Fodstad O, Tan M. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α. Cancer Res 2016;76:2231-42. [PMID: 27197253 DOI: 10.1158/0008-5472.CAN-15-1538] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
19 Khan M, Arooj S, Wang H. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy. Front Immunol 2021;12:651634. [PMID: 34531847 DOI: 10.3389/fimmu.2021.651634] [Reference Citation Analysis]
20 Blazquez JL, Benyamine A, Pasero C, Olive D. New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity. Front Immunol 2018;9:1601. [PMID: 30050536 DOI: 10.3389/fimmu.2018.01601] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
21 Huang L, Zhou Y, Sun Q, Cao L, Zhang X. Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma. Cancer Biomark 2021. [PMID: 34459388 DOI: 10.3233/CBM-210178] [Reference Citation Analysis]
22 Sun J, Lai H, Shen D, Wu P, Yang J, Sun Z, Guo Y. Reduced sB7-H3 Expression in the Peripheral Blood of Systemic Lupus Erythematosus Patients. J Immunol Res 2017;2017:5728512. [PMID: 29423417 DOI: 10.1155/2017/5728512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]